Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Najib Dally

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Frontiers in Neurology|May 31, 2024
Efficacy and safety of Apixaban in the treatment of cerebral venous sinus thrombosis: a multi-center studyNaaem Simaan, Issa Metanis, Asaf Honig, et al.
Leukemia Research|September 15, 2015
Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practiceMartin H Ellis, Noa Lavi, Elena Mishchenko, et al.
Leukemia Research|June 2, 2019
Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemiaTamar Tadmor, Ilana Levy, Yair Herishanu, et al.
European Journal of Haematology|April 2, 2015
Outcomes of light-chain amyloidosis patients treated with first-line bortezomib: a collaborative retrospective multicenter assessmentMoshe E Gatt, Izhar Hardan, Evgeni Chubar, et al.
Leukemia & Lymphoma|September 14, 2017
Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?Ohad S Bentur, Ronit Gurion, Anat Gafter-Gvili, et al.
Haematologica|July 29, 2021
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemiaOhad Benjamini, Lior Rokach, Gilad Itchaki, et al.
Palliative Medicine|March 25, 2021
Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapyLiza Barki-Harrington, Orna Baron-Epel, Adir Shaulov, et al.
Blood Advances|December 5, 2024
Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort studyOfir Wolach, Itai Levi, Boaz Nachmias, et al.
Journal of Clinical Medicine|September 28, 2023
MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin LevelYael Haring, Noa Goldschmidt, Shaimaa Taha, et al.
American Journal of Hematology|January 25, 2013
Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter studyDrorit Merkel, Kalman Filanovsky, Anat Gafter-Gvili, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Neurology|May 31, 2024
Efficacy and safety of Apixaban in the treatment of cerebral venous sinus thrombosis: a multi-center studyNaaem Simaan, Issa Metanis, Asaf Honig, et al.
Leukemia Research|September 15, 2015
Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practiceMartin H Ellis, Noa Lavi, Elena Mishchenko, et al.
Leukemia Research|June 2, 2019
Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemiaTamar Tadmor, Ilana Levy, Yair Herishanu, et al.
European Journal of Haematology|April 2, 2015
Outcomes of light-chain amyloidosis patients treated with first-line bortezomib: a collaborative retrospective multicenter assessmentMoshe E Gatt, Izhar Hardan, Evgeni Chubar, et al.
Leukemia & Lymphoma|September 14, 2017
Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?Ohad S Bentur, Ronit Gurion, Anat Gafter-Gvili, et al.
Haematologica|July 29, 2021
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemiaOhad Benjamini, Lior Rokach, Gilad Itchaki, et al.
Palliative Medicine|March 25, 2021
Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapyLiza Barki-Harrington, Orna Baron-Epel, Adir Shaulov, et al.
Blood Advances|December 5, 2024
Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort studyOfir Wolach, Itai Levi, Boaz Nachmias, et al.
Journal of Clinical Medicine|September 28, 2023
MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin LevelYael Haring, Noa Goldschmidt, Shaimaa Taha, et al.
American Journal of Hematology|January 25, 2013
Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter studyDrorit Merkel, Kalman Filanovsky, Anat Gafter-Gvili, et al.
Pageof 4